Zynex Inc (ZYXI) Company Profile & Statistics

Zynex Inc
ZYXI
(Nasdaq - US)
N/A
10.86
+0.18 (+1.69%)
in:usd•As of: May 14, 2024 15:59 UTC -4
Open
11.06
High
11.06
Low
10.73

About Zynex Inc

CEO

Thomas Sandgaard,

Headquarters

9655 maroon circle

englewood, co 80112, united states

Auditor

Marcum LLP

Employees

1,100

Share Holders

188

Website

www.zynex.com

Industry

medical specialties

Sector

health technology

Company Overview

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.

Zynex Inc Statistics

Valuation Measures

Market Capitalization ²	345.02M
Enterprise Value	358.70M
Enterprise Value/EBITDA (ttm)	23.91
Price to Earnings Ratio (ttm)	45.61
Price to Book (mrq)	10.07
Price to Sales (ttm)	1.77
Price to Cash (ytd)	25.49

Profitability

Gross Margin (ttm)	79.13%
Operating Margin (ttm)	4.33%
Profit Margin (ttm)	5.24%
Return on Equity (ttm)	16.34%
Return on Invested Capital (ttm)	9.35%
Return on Assets (ttm)	5.76%

Income Statement

Revenue (ttm)	184.32M
Revenue Per Share (ttm)	5.73
Gross Profit (ttm)	145.96M
EBITDA (ttm)³	15.00M
Net Income Avi to Common (ttm)	9.73M
Diluted EPS (ttm)	0.23

Share Statistics

Beta (5Y Monthly)	0.49
52-Week Change	13.01%
S&P500 52-Week Change	26.85%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	32.17M
Dividend Yield	0.00%
Float ⁴	15.21M
% Held by Insiders	52.13%
% Held by Institutions	29.68%

Balance Sheet

Total Cash (mrq)	44.58M
Total Cash Per Share (mrq)	1.39
Total Debt (mrq)	58.26M
Total Debt/Equity (mrq)	126.29%
Current Ratio (mrq)	4.74%
Quick Ratio (mrq)	2.87%
Book Value Per Share (mrq)	1.40

Cash Flow

Operating Cash Flow Per Share (ytd)	0.49
Free Cash Flow (ytd)	16.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Zynex Inc

Trade With A Regulated Broker